Investigation of the aortic pulse wave velocity in patients with gilbert's syndrome

Clinical and Experimental Hypertension

Volumn 35, Issue 7, 2013, Pages 512-515

  Arslan, Erol ^a   Çakar, Mustafa ^a   Şarlak, Hakan ^a   Kilinç, Ali ^a   Demirbaş, Şeref ^a   Ay, Seyit Ahmet ^a   Karaman, Murat ^a   Bulucu, Fatih ^a   Saǧlam, Kenan ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Arterial stiffness; Dysfunction; Endothelial; Gilbert's syndrome; Hyperbilirubinemia; Pulse wave velocity

Indexed keywords

BILIRUBIN; GLUCURONOSYLTRANSFERASE;

ADULT; AORTA; ARTERIAL STIFFNESS; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD CHEMISTRY; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GILBERT DISEASE; HUMAN; LIVER; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MORBIDITY; PREDICTIVE VALUE; PULSE WAVE;

ADULT; BILIRUBIN; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; GILBERT DISEASE; GLUCURONOSYLTRANSFERASE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PULSE WAVE ANALYSIS; VASCULAR STIFFNESS; VASODILATION; YOUNG ADULT;

EID: 84885199824     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641963.2012.758277     Document Type: Article

References (24)

1. Sieg A, Arab L, Schlierf G, Stiehl A, Die KB. Pravalenz des Gilbert-syndromes in Deutschland. Dtsch Med Wochenschr 1987; 112(31/32):1206-1208
2. Schwertner HA, Vitek L. Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin. Atherosclerosis 2008; 198 (1):1-11
3. Bilirubin KJ. An endogenous product of heme degradation with both cytotoxic and cytoprotective properties. Mol Pharmacol 2004; 66(4):773-779
4. Djousse L, Levy D, Cupples LA, Evans JC, D?Agostino RB, Ellison RC. Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am J Cardiol 2001; 87(10):1196-1200
5. Temme E, Zhang J, Schouten E, Kesteloot H. Serum bilirubin and 10-year mortality risk in a Belgian population. Cancer Caus Control 2001; 12(10):887-894
6. Troughton JA, Woodside JV, Young IS, et al. Bilirubin and coronary heart disease risk in the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Eur J Cardiovasc Prev Rehabil 2007; 14(1):79-84
7. ErdoganD,Gullu H, Yildirim E, et al. Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women. Atherosclerosis 2006; 184(2):431-437
8. Novotny L, Vitek L. Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies. Exp Biol Med 2003; 228(5):568-571
9. Perlstein TS, Pande RL, Beckman JA, Creager MA. Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease. Arterioscler Thromb Vasc Biol 2008; 28(1):166-172
10. Kostis JB, Lawrence-Nelson J, Ranjan R, Wilson AC, Kostis WJ, Lacy CR. Association of increased pulse pressure with the development of heart failure in sheep. Am J Hypertens 2001; 14(8): 798-803
11. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001; 104(22):2673-2678
12. Rauchschwalbe SK, Zuhlsdorf MT, Schuhly U, Kuhlmann J. Predicting the risk of sporadic elevated bilirubin levels and diagnosing Gilbert's syndrome by genotyping UGT1A1*28 promoter polymorphism. Int J Clin Pharmacol Ther 2002; 40(6): 233-240
13. Stocker R, Yamamoto Y, McDonagh A, Glazer A, Ames B. Bilirubin is an antioxidant of possible physiological importance. Science 1987; 235(4792):1043-1046
14. Abraham NG, Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 2008; 60(1):79-127
15. Clark JE, Foresti R, Sarathchandra P, Kaur H, Green CJ, Motterlini R. Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction. AJP-Heart and Circ Physiol 2000; 278(2):H643-H651
16. Leopold JA, Loscalzo J. Oxidative risk for atherothrombotic cardiovascular disease. Free Radic Biol Med 2009; 47(12):1673-1706
17. Esper RJ, Nordaby RA, Vilarino JO, Paragano A, Cacharron JL, Machado RA. Endothelial dysfunction: a comprehensive appraisal. Cardiovasc Diabetol 2006; 5:4
18. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004; 109(23 Suppl 1):III27-III32
19. Lieberman EH, Gerhard MD, Uehata A, et al. Flow-induced vasodilation of the human brachial artery is impaired in patients
20. Qureshi G, Brown R, Salciccioli L, et al. Relationship between aortic atherosclerosis and non-invasive measures of arterial stiffness. Atherosclerosis 2007; 195(2):e190-e194
21. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000; 87(10):840-844
22. Maruhashi T, Soga J, Fujimura N, et al. Hyperbilirubinemia, augmentation of endothelial function, and decrease in oxidative stress in Gilbert syndrome. Circulation 2012; 126(5):598-603
23. Vitek L, Jirsa M, Brodanova M, et al. Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis 2002;160(2):449-456
24. Yesilova Z, SerdarM, ErcinCN, et al.Decreased oxidation susceptibility of plasma low density lipoproteins in patients with Gilbert's syndrome. J Gastroenterol Hepatol 2008; 23(10):1556-1560